Allstate Vs. Progressive: Buy Allstate's Deep-Value Multiple Not Progressive's Premium Run

Allstate reported Q1 2026 EPS of $10.65 vs $7.24 expected (47.1% beat), with the homeowners book flipping to a $685M underwriting profit and the combined ratio falling to 82.0 from its prior-year loss period; catastrophe losses declined 43.7% to $1.24B. Progressive’s Q1 revenue rose 8.8% to $22.19B and policies in force increased 9% to ~39.6M, but EPS of $4.96 only slightly beat $4.88 and the combined ratio ticked up to 86.4 from 86.0. The article highlights stronger valuation/returns and more decisive capital returns for Allstate (a $4.0B buyback plus $1.08 quarterly dividend) versus Progressive’s pricing/underwriting friction (Florida policyholder credit overhang and a rising combined-ratio risk).

Analysis

ALL looks better positioned for a rerate because the market can now underwrite a cleaner capital-return story: when underwriting stops bleeding, buybacks matter more, and at a low single-digit multiple that can force multiple expansion quickly. The second-order loser is any auto-heavy personal lines carrier that has been relying on scale and rate increases rather than true margin repair; if the pricing environment stays rational, share gains can migrate toward the firms with broader bundling and better capital flexibility, not just the pure auto specialists.

The key risk is that ALL’s improvement is more fragile than the headline beat suggests: homeowners profitability is highly path-dependent, so one normal cat season can erase a large chunk of the margin reset in a single quarter. For PGR, the issue is not growth, it’s diminishing marginal returns on growth—if policy gains keep coming but the ratio won’t improve, the market eventually treats that as premium growth bought at the expense of underwriting leverage. Watch the next 1-2 quarters for either a cat-normalized ALL combined ratio above the mid-80s or a PGR ratio that stays stuck despite continued policy growth; those are the fastest falsifiers.

Best expression is a relative-value trade rather than a naked long: long ALL / short PGR for 3-6 months, sized to neutralize market beta and isolate underwriting dispersion. Entry is attractive on any post-earnings retrace in ALL or strength in PGR, with the spread thesis strongest if the market keeps paying up for top-line growth while ignoring that the incremental dollar of growth at PGR is not converting into earnings power. Contrarian view: the market may be too eager to declare PGR’s margin stall structural; if pricing discipline in auto re-accelerates, the short can hurt quickly, so a decisive move lower in PGR likely needs confirmation from the next combined ratio print, not just one quarter of noise.

Key Decisions for Investors

• Initiate a 3-6 month long ALL / short PGR pair trade, dollar-neutral, targeting valuation convergence; thesis breaks if PGR re-accelerates margin expansion or ALL’s next combined ratio reverts above the mid-80s.
• If you want outright exposure, buy ALL on any post-earnings pullback rather than chasing strength; the setup is supported by capital returns and a low multiple, but only if catastrophe losses remain contained over the next 1-2 quarters.
• Use PGR as a tactical short only on rallies: the clean trigger is another quarter of policy growth with flat-to-worse underwriting; cover if Q2/Q3 combined ratio improves meaningfully or if management signals pricing firming.
• Watch KIE/IAK for sector confirmation: if personal-lines peers fail to participate while ALL outperforms, the market is likely rewarding capital return and diversification over pure auto growth.
• Set a hard stop on the relative-value trade if ALL’s combined ratio moves back above ~86-87 with normal weather, or if PGR’s combined ratio falls back toward prior lows, because that would invalidate the dispersion thesis.